Last summer, Ironwood pink-slipped 40 staffers as it prepared to split itself into two companies. But it turns out those layoffs were only the beginning.
Chairman Philip Hampton, who joined GlaxoSmithKline after its Novartis asset swap upped the ante in consumer health, is now stepping down as the British drugmaker prepares to split up the business.
Chairman Philip Hampton, who joined GlaxoSmithKline after its Novartis asset swap upped the ante in consumer health, is now stepping down as the British drugmaker prepares to split up the business.